spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.

 

For further information please contact:

Advertising
Dean Dalton

Editorial
Aimee-Rose O'Driscoll

We're also on Twitter! Follow us @EPCmagazine

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


View the digital version of EPC




 

epc
 
 
Featured in this issue
Therapeutic Innovation
Ageing Populations

Beyond a Single Pill


Capsugel’s Sven Stegemann describes why a ‘one-size-fits-all’ approach to drug design is no longer sufficient in the treatment of diseases of ageing. Various patient-centric products should be explored – and are sometimes essential to adherence in elderly populations.
Labs & Logistics
Laboratory Relocation

The Right Move


Potential research disruption, damage to samples and heavy costs can strike fear into any company considering a laboratory move. John Best at Andrew Porter Ltd tells us how to make a success of any relocation.
  Regional Focus
Russia Focus: Risk-Based Monitoring

Instant Results


While there are huge cost savings to be had from implementing risk-based monitoring, the benefits can take years to surface. Synergy Research Group’s Igor Stefanov and John Barker offer Russia as a solution to those looking for quicker rewards.

spacer
Edited by
Dr Graham Hughes,
Consultant in
Pharmaceutical
Development
Published quarterly in
March, June,
September and December
Banner of PCI.EPC on Samedan
Banner of Samedan app.EPC on Samedan
Banner of Woodley.EPC on Samedan
 
Industry Events

Annual World Drug Manufacturing Summit

1-3 December 2014, Berlin, Germany

Now in its 13th year, the World Drug Manufacturing Summit provides the key tools to overcome the biggest threats facing pharma manufacturers today.
More info >>

 
News and Press Releases

Almac Appoints Two Marketing Directors

Two key positions have been created at Almac Group, the pharmaceutical contract development and manufacturing organisation, expanding their global marketing team. Matt Cocking joins as Market Development Director for their Clinical Technologies business unit and will be responsible for developing the marketing plan in line with business strategy.  Matt has over 10 years’ experience as a senior marketing leader and formally held the position of Director of Marketing at Philadelphia based clinical trial software solutions company, Y Prime.
More info >>

air transport logo

 

White Papers

High Containment FIBCs Offer a Safe and Cost Effective Alternative to their Rigid Counterparts

ILC Dover

As the need for powder containment and manufacturing in accordance with cGMP standards has grown over the years, companies have sought new alternatives to rigid IBCs. Recently high containment Flexible Intermediate Bulk Containers (FIBCs) have emerged which offer an alternative that provides both powder containment and the benefits of shipping with flexibles.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement